Skip to content

Drug interactions

Anagrelide + Trifluoperazine

Severity: Moderate

Anagrelide and Trifluoperazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Anagrelide and trifluoperazine can each prolong the QT interval, so combined use increases the chance of serious ventricular arrhythmias such as torsades de pointes. Patients with heart disease, electrolyte abnormalities or other QT-prolonging drugs are at greater risk.

What this interaction means in plain words

Anagrelide and Trifluoperazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation through delayed cardiac repolarization.

What to do

Check a baseline ECG and correct potassium and magnesium abnormalities before combining. Monitor the QTc periodically and reduce or stop one agent if significant prolongation occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anagrelide and Trifluoperazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Anagrelide with Trifluoperazine?

MediHelp rates the interaction as moderate. Anagrelide and Trifluoperazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Anagrelide and trifluoperazine can each prolong the QT interval, so combined use increases the chance of serious ventricular arrhythmias such as torsades de pointes. Patients with heart disease, electrolyte abnormalities or other QT-prolonging drugs are at greater risk.

How serious is the interaction between Anagrelide and Trifluoperazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check a baseline ECG and correct potassium and magnesium abnormalities before combining. Monitor the QTc periodically and reduce or stop one agent if significant prolongation occurs.

What other medicines interact with Anagrelide?

MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in